Nolet Chris

Related Filers (5)

Ownership (21)

3
Thursday, 1/25/2024
ArriVent Biopharma, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/8/2023
Jasper Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/5/2023
Revance Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/17/2023
POLARITYTE, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/13/2022
Jasper Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/4/2022
POLARITYTE, INC.: Statement of changes in beneficial ownership of securities
4/A
Friday, 5/13/2022
Revance Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/6/2022
Revance Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/23/2022
Jasper Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 10/1/2021
Jasper Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 5/7/2021
Revance Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/15/2021
Viela Bio, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/5/2021
POLARITYTE, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/23/2020
Viela Bio, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/15/2020
Revance Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/7/2020
POLARITYTE, INC.: Statement of changes in beneficial ownership of securities
3
Monday, 4/6/2020
POLARITYTE, INC.: Initial statement of beneficial ownership of securities
4
Wednesday, 10/2/2019
Viela Bio, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/2/2019
Viela Bio, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 7/18/2019
Revance Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/18/2019
Revance Therapeutics, Inc.: Initial statement of beneficial ownership of securities
Show More